Allergan, Irvine, Calif., received the go-ahead Monday for the antiaging drug, a popular treatment for facial wrinkles. FDA approval meant Allergan was able to beging advertising the drug, which has been in use for more than a decade.
Billings for the account are estimated at $40 million to $50 million.
Grey Worldwide will handle the consumer advertising, MediaCom will be used for media planning and buying and Grey Healthcare will implement the professional, direct and interactive marketing.
Grey beat out Publicis Groupe's Saatchi & Saatchi Healthcare, Cordiant Communications' Bates Healthworld, and Sudler and Hennessey, all New York.